
    
      This prospective, open label, multi-center, observational, single arm registry is designed to
      monitor the AtriCure Synergy Ablation System continued safety and efficacy during the
      peri-procedural and long-term phase during commercial use in patients being treated for
      non-paroxysmal forms of atrial fibrillation who are undergoing a concomitant open, on-pump
      cardiac surgical procedure.
    
  